NYSCC Suppliers’ Day Visit us at Booth 2049 May 19–20 Javits Center, NYC 6 days away

Access Ingredients and Sandream Specialties are now Vivify Beauty Care. All your ingredients, one source.

AccessCARE RETINAL-S

1.0% Encapsulated Retinal for Faster Conversion and Clinically Demonstrated Results

INCI Name: Water, Butylene Glycol, Macadamia Ternifolia Seed Oil, Caprylic/Capric Triglyceride, Hydrogenated Lecithin, Glycerin, 1,2-Hexanediol, Cholesterol, Brassica Campestris (Rapeseed) Sterols, PEG-5 Rapeseed Sterol, Ceteth-3, Ceteth-5, Tocopherol, Aluminum/Magnesium Hydroxide Stearate, Potassium Cetyl Phosphate, Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate

AccessCARE RETINAL-S is a 1.0% Retinal active stabilized using the same 3-step encapsulation technology, designed for controlled release and efficient skin delivery. Retinal sits one conversion step closer to retinoic acid than Retinol, and RETINAL-S is engineered for faster conversion (~11× in comparative studies) alongside enhanced stability against heat and light. Clinical evaluation demonstrated 18-week wrinkle improvement and +9.4% dermal thickness improvement.

Solubility Notes:

Water-based liposomal dispersion; both/dual-soluble due to encapsulation. Incorporate into the water phase; protect from excessive heat and light during processing.

Log In or register to access Safety and Technical Data Sheets and save products as favorites.

Perfect For These Applications

Other cosmetic uses possible—contact us for formulation guidance.

  • Clinically-Backed Anti-Aging Serums
    Supported by demonstrated 18-week wrinkle improvement and dermal thickness gains.
  • Fast-Acting Renewal Treatments
    ~11× faster conversion toward retinoic acid supports quicker-acting renewal claims versus standard retinol.
  • Retinol-Alternative/Upgrade Formulations
    Offers a more direct conversion pathway for brands positioning beyond entry-level retinol.
  • Firming & Dermal-Density Treatments
    +9.4% dermal thickness improvement supports firming and plumping claims.

Performance & Formulation Insights

How It Works: Retinal (retinaldehyde) is a Vitamin A conversion intermediate, requiring one fewer step to reach retinoic acid than Retinol. RETINAL-S applies the same 3-step encapsulation platform (LDH primary liposome → MLV secondary liposome → combined final encapsulation) to protect this reactive intermediate from heat and light while enabling controlled, efficient delivery. Comparative studies showed ~11× faster conversion toward retinoic acid, translating into clinically measured 18-week wrinkle improvement and +9.4% dermal thickness increase.

Formulation Guidelines

Dose based on the 1.0% Retinal concentration of the complex to reach your target finished-product Retinal percentage. Incorporate into the water phase; maintain standard Vitamin A handling precautions (protect from light/heat, opaque or airless packaging) despite encapsulation.

Key Formulation Benefits:

  • Faster Conversion: ~11× faster conversion toward retinoic acid in comparative studies.
  • Clinically Demonstrated Efficacy: 18-week wrinkle improvement and +9.4% dermal thickness improvement.
  • Enhanced Stability: Encapsulation protects against heat and light degradation.
  • Controlled, Efficient Delivery: Skin-mimetic MLV structures support efficient skin delivery.

Heading #1
Benefits
Anti-Aging & Anti-Wrinkle, Firming & Lifting, Skin Elasticity, Wrinkle Reduction
INCI Name
Water, Butylene Glycol, Macadamia Ternifolia Seed Oil, Caprylic/Capric Triglyceride, Hydrogenated Lecithin, Glycerin, 1,2-Hexanediol, Cholesterol, Brassica Campestris (Rapeseed) Sterols, PEG-5 Rapeseed Sterol, Ceteth-3, Ceteth-5, Tocopherol, Aluminum/Magnesium Hydroxide Stearate, Potassium Cetyl Phosphate, Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate
Usage Rate
1%-20%
Active Type
Vitamin A (Retinoids/Retinol), Vitamins & Derivatives
Solubility
Both/Dual-Soluble
Application Area
Face
Physical Form
Liquid/Solution
Certifications

Frequently Asked Questions About AccessCARE RETINAL-S

Retinal requires one fewer conversion step to reach retinoic acid, and RETINAL-S showed ~11× faster conversion in comparative studies.
18-week wrinkle improvement and +9.4% dermal thickness improvement were demonstrated in clinical evaluation.
Dose based on the 1.0% Retinal concentration of the complex to reach your target finished-product Retinal percentage.

Contact An Expert

Only 4 fields to get started. An expert will respond within 1 business day.

AccessCARE RETINAL-S